NBIA scientists will meet to share their research Oct. 13-15 in Lausanne, Switzerland, at the 8th International NBIA Symposium. More than 20 scientists and physicians from around the world will present the results of their NBIA projects, including the latest developments in current NBIA research. The high-level program will include presentations especially on the most common NBIA variants PKAN, BPAN, MPAN, PLAN and FAHN and beyond, followed by discussion sessions on the necessary next steps in the diverse NBIA research branches.
In a confidential atmosphere, the symposium also offers the opportunity for researchers to get to know each other personally and to network, also with a view to future collaborations on research projects. Clinicians, most of whom also have research experience in NBIA, can also share their experiences with treatment options for NBIA patients and thus take new insights back with them into their daily clinical routine.
Hoffnungsbaum e.V. is among the sponsors of this momentous NBIA event, the first face-to-face meeting of NBIA researchers since 2017, with €5,000. Due to the pandemic, the 2020 symposium was held online only. Our U.S. partner organization, the NBIA Disorders Accociation, is contributing $5,000 in travel grants for early career scientists.
The symposium is organized by the Swiss NBIA patient organization NBIA Suisse under the leadership of its chairperson Fatemeh Mollet. Under the chairmanship of Prof. Dr. Thomas Klopstock, head of the NBIA Center at the Friedrich Baur Institute in Munich, a 5-member scientific committee has taken over the program design. For Hoffnungsbaum e.V. our chairman Markus Nielbock participated as a patient representative.
Symposium website: https://nbiasuisse.org/8th-international-symposium-on-nbia/